International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 157-247 doi: 10.5281/zenodo.16416888
Original Article
Clinical Study of Syndactyly
 ,
 ,
 ,
Published
July 19, 2025
Abstract

Background: Syndactyly, defined as the congenital fusion of two or more digits, results from failed differentiation or incomplete separation during embryonic development. It is recognized as the second most frequently occurring congenital anomaly of the upper limb, with an estimated prevalence of 1 in every 2,000 to 3,000 live births. This study aims to explore the clinical and anatomical characteristics associated with congenital syndactyly.

Methods: This retrospective analysis included patients diagnosed with congenital syndactyly and admitted to the Department of Plastic and Reconstructive Surgery at GMCH, Guwahati, over a 20-month period. Following ethical committee approval, relevant clinical data and patient images were retrieved from the hospital’s medical records and departmental documentation.

Results: Twelve patients with congenital syndactyly were evaluated. Findings indicated a higher prevalence among male patients, frequent occurrence of bilateral and symmetrical involvement, and most commonly, the involvement of the third interdigital space. Three patients were diagnosed with Apert syndrome. Additional anomalies, including brachydactyly and polydactyly, were noted in four patients.

Conclusions: The observations in this study closely align with previously published data. This investigation enhances the understanding of the clinical profile and anatomical patterns associated with syndactyly.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1934 Views
182 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved